Press Release

(October 14, 2019) - Two New Sets of Barcode Convert Primers are Optimized for Ion Torrent* Sequencers

SAN DIEGO (October 14, 2019) – TriLink BioTechnologies, a Maravai LifeSciences company and leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, introduces two new primer sets for its CleanTag® kit. The new Ion Torrent Convert barcode primer sets e...

(November 29, 2018) - TriLink BioTechnologies, a Maravai LifeSciences company and a leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, announced today that the company’s CleanTag® Small RNA Library Prep Kit was the enabling technology in a new study of next-generation sequencing of small RNAs from single cells. The study, Efficient Production of On-Target Reads for Small RNA Sequenci...

(October 9, 2018) - Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced that it has hired Christopher Shaffer as senior director of oligonucleotide process development for TriLink BioTechnologies. In this new position, Shaffer will develop and refine processes that improve overall efficiency and will be instrumental when TriLink relocates to a ...

(September 10, 2018) - Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego. TriLink will consolidate its San Diego facilities into a new 95,000-square-foot space with an option to expand for fut...

(November 27, 2017) - TriLink BioTechnologies, a leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, announced today that Michael Houston, Ph.D., has joined the company as chief scientific officer. In this role he is responsible for the company’s R&D as well as scientific thought leadership.

Houston holds a Ph.D. in bioorganic chemistry and has worked for a range of biotechnology and p...

(October 16, 2017) - TriLink BioTechnologies, a leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, announced today that Brian Neel has joined the company as chief operating officer. In that role, Neel will be responsible for TriLink BioTechnologies operations including site leadership, facilities, sourcing and manufacturing.

Neel brings more than 15 years of experience in the life science ...

(January 10, 2017) - TriLink BioTechnologies, a leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, introduces CleanCap – a patented mRNA capping method that overcomes many drawbacks of existing technology. CleanCap, which is available built into TriLink BioTechnologies products or in bulk for customer use, exhibits superior capping efficiencies for higher yield, along with time and cost savings....

(October 20, 2016) - Maravai LifeSciences, a transformative company in the life science research market, announced today that it has acquired TriLink BioTechnologies, leaders in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics. The acquisition fits with Maravai LifeSciences’ goal of creating a market-leading life science business by bringing investment, strong and experienced leadership, processes and be...

(March 15, 2015) - TriLink BioTechnologies, a leader in oligonucleotide and mRNA synthesis for research, diagnostics and therapeutics, introduces CleanTag® – a new technology that addresses one of the biggest problems in NGS library preparation – adapter dimer formation. CleanTag’s modified adapters block adapter-adapter formation, which leads to significantly higher quality sequencing data and increases mappable s...

Jennifer Dahlgren
Dahlgren Communications
Phone: (530) 263-6817
Email: [email protected]


David Weber, Chief Commercial Officer
Maravai LifeSciences
Phone: (650) 697-3600
Email: [email protected]